eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cytomegalic inclusion disease |
| Comorbidity | C0235974|pancreatic cancer |
| Sentences | 1 |
| PubMedID- 22757972 | Materials and methods: transfected pancreatic cancer cells bxpc-3 with recombinant plasmid psilencer4.1-cytomegalovirus neo-htert-sirna were selected as target and divided into 9 groups: (1) t1 group (psilencer4.1-cmv neo-htert1-sirna), (2) t2 group (psilencer4.1-cmv neo-htert2-sirna), (3) l group (lipofectamine) (4) m group (mismatch group psilence4.1-cmv, as negative control), (5) c group (cell group without transfection), (6) blank and gemcitabine group, (7) mismatch sirna and gemcitabine group, (8) htert1-sirna and gemcitabine group, and (9) htert2-sirna and gemcitabine group. |
Page: 1